Inhibition of proprotein convertase subtilisin-like kexin type 9 (PCSK9) potentiates anti-angiogenic therapy in colorectal cancer liver metastases https://www.biorxiv.org/content/10.1101/2023.05.29.542731v1?med=mas
Inhibition of proprotein convertase subtilisin-like kexin type 9 (PCSK9) potentiates anti-angiogenic therapy in colorectal cancer liver metastases https://www.biorxiv.org/content/10.1101/2023.05.29.542731v1?med=mas